tirzepatide in the morning or night Timing at | Weight Loss Guide Replying to @Didrey should we

Retatrutide is a synthetic triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously

The question is who it will serve, and whether the ultimate prize is treatment, profit, or ownership of hunger itself

And right now, the buzz around GLP-1 medications like Tirzepatide is deafeningfor good reason

Telehealth prescribing: The ability of out-of-state providers to prescribe medications via telehealth varies by state

The medication appears to affect central appetite pathways, with GLP-1 receptors found in brain regions responsible for appetite regulation, including the hypothalamus

Gut barrier disruption and chronic disease